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Abstract: Acceptance and commitment therapy (ACT) is an adapted form of cognitive behavioural
therapy. ACT focuses on how thinking affects behaviour and promotes psychological flexibility. The
prevalence of psychological distress among people living with cardiovascular disease (CVD) and/or
type 2 diabetes mellitus (T2DM) is high, and ACT may offer an alternative treatment approach.
This scoping review explored the use of ACT as an intervention to support adults living with CVD
and/or T2DM. A systematic search of the literature resulted in the inclusion of 15 studies. Studies
were reviewed using the Joanna Briggs Institute approach to conducting scoping reviews. Most
studies (n = 13) related to people living with T2DM, and most (n = 10) used a pre-post design,
four studies were randomised controlled trials, and one was a qualitative study. Eight studies
reported an improvement in the outcome(s) assessed post-intervention, suggesting that ACT was an
acceptable and valid intervention to support people living with CVD or T2DM. However, studies
were underpowered and only limited studies involved people living with CVD. ACT was assessed
as a valuable approach to improve a range of patient-reported outcomes for those living with CVD
or T2DM, and further research involving robust study designs and larger cohorts are warranted.
Keywords: acceptance and commitment therapy; cardiovascular; diabetes
1. Introduction
The number of people living with cardiovascular disease (CVD), which includes coro-
nary heart disease and stroke, and Type 2 Diabetes Mellitus (T2DM), continues to grow
worldwide [1]. More people die from CVD per year than any other condition, accounting
for 31% of all deaths in 2016 [2]. Diabetes is also a global issue, with approximately 11%
of the adult population known to be living with the condition [3], and the two conditions
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commonly co-occur [4]. The prevention and management of both conditions are under-
pinned by the need to adopt a healthy lifestyle through self-management practices relating
to diet and exercise, managing stress and medication management [2,5]. Diabetes is a risk
factor for cardiovascular disease and there is a high prevalence of co-morbidity [2].
Structured Cardiac Rehabilitation (C.R.) programmes, and diabetes care, focus on
improving lifestyle behaviours to reduce smoking, engage with dietary adjustments and
increase physical activity. Evidence on the uptake of self-management behaviours to
prevent illness and improve health highlight the challenges and variable effectiveness
of self-management interventions of long-term conditions [6]. Despite improvements to
healthcare services, gaps remain between healthcare advice, patient implementation of
advice, management of their condition, and clinical outcomes. Non-attendance at C.R.
is associated with suboptimal clinical outcomes; this is applicable for those who never
attend and those who drop out. A recent systematic review and interpretative synthesis
highlights the complex nature of self-management of T2DM. Making lifestyle changes is
challenging, and understanding and accounting for the context in which people live, their
social influences, cultural and societal norms, the physical environment, and physiological
and psychological factors are important [7].
An interplay exists between patient engagement and implementation of healthcare
advice and the individual’s processes in making (un/conscious) decisions, and attending,
engaging, and implementing self-management behaviours. In this context, patients are
managing behavioural, cognitive, emotional challenges and, potentially, any pre-existing
experiences and beliefs as part of their day-to-day management. It is the role of healthcare
services to provide interventions to support patients to navigate and manage such psy-
chological challenges. Moreover, an individual’s psychological state may further impact
engagement with healthcare advice and self-management behaviours. For people with
either CVD and T2DM, depression and anxiety are prevalent comorbidities. These patients
may experience additional psychological distress whilst managing and implementing
behavioural advice associated with increased mortality and morbidity [8]. In diabetes, this
is referred to specifically as “diabetes distress” [9], common in patients with T2DM [10]. Di-
abetes distress can be influenced by numerous psychological variables, including (though
not limited to) illness perceptions and beliefs, self-efficacy, coping strategies, emotional
regulation and psychological flexibility [11].
Acceptance and commitment therapy (ACT) is an adapted form of cognitive be-
havioural therapy (CBT). Unlike Cognitive Behavioural Therapy (CBT) and traditional
behavioural-based approaches, ACT focuses on how thinking affects behaviour, and pro-
motes psychological flexibility [12]
In comparison to CBT, ACT does not attempt to change beliefs (e.g., replace negative
thoughts with adaptive thoughts), and it does not seek to remove the psychological distress
(though this may be a positive outcome). ACT promotes connection to the present moment
and engagement in values-based action to help people create a sense of meaning and
increase their psychological flexibility [13]
ACT has been used with people living with a wide range of conditions [14], as
an intervention to improve self-management [15], to improve medication management
behaviours among adolescents living with diabetes [16], and for people living with cardiac
disease [17]. Given the prevalence of psychological distress in patients living with CVD
and/or T2DM, ACT may be an ideal intervention to integrate into the healthcare offer.
Previous reviews have evaluated the application of ACT across (non-specific) long-term
conditions [14].
Healthcare services need to be innovative and respond to personalised needs and
there is a clear need for improvement in CVD and diabetes services. This review sought
to synthesise the research literature on the use of ACT as an intervention to support the
management of both conditions.
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2. Materials and Methods
This review was conducted in accordance with the Joanna Briggs Institute (JBI; May
2020) guidelines for scoping reviews involving narrative synthesis. Scoping reviews are rig-
orous processes carried out to understand a variety of studies with several methodologies
and outcome measures [18].
2.1. Search Strategy and Inclusion Criteria
Eight electronic bibliographic databases (Embase, Medline, PsycINFO, CINAHL, Web
of Science, Cochrane Library, Scopus, JBI and Google Scholar) were searched in May 2020
(15 May) with an updated search run in November 2020 (20 November). Keywords and
Medical Subject Headings (MeSH) terms were used to identify relevant literature. Key
terms relevant to ACT and diabetes and cardiovascular care were used (see Appendix A).
2.2. Study Selection and Inclusion Criteria
The included studies met the following eligibility criteria: (1) participants, identified
as adults diagnosed with type 2 diabetes and/or cardiovascular disease (defined as a group
of disorders of the heart and blood vessels); (2) intervention, ACT (3); Design, all study
designs; and (4) context, all settings. We excluded studies where full text was unavailable.
No date restrictions were implemented for the search period or article publication date.
We considered all study designs that examined attributes of interventions, implementation,
feasibility, acceptability and the risks or benefits of ACT. Empirical research published in a
peer-reviewed journal and any language were included. At the initial stage, all studies were
exported to EndNote and duplicates were eliminated. Titles and abstracts were screened
against the inclusion criteria by three independent reviewers (L.W., A.R., I.J.). One study
was excluded because the full-text study was not available [19].
The abstracts in English of six studies published in Farsi [20–25] and two studies
published in German [26,27] were screened for inclusion, and all included at this stage.
The Google Translator tool was used to translate the Farsi studies [20–25] for full-text
screening. The accuracy of Google Translate was found to be around 90% [28], and a native
speaker (AR) sought to sense-check the accuracy of the verbatim translation and made any
corrections to the text as required. The German studies [26,27] were translated into English
by a bilingual speaker known to an author and fluent in both languages. Six studies [20–25]
were translated from Farsi to English by a native Farsi speaker also fluent in English (AR).
2.3. Quality Appraisal and Data Extraction
The JBI critical appraisal tools were used to evaluate the quality of the included
studies [29]. Studies were assessed in pairs for quality by nine independent reviewers
(L.W., A.R., D.L., H.W., I.J., C.S., D.T., F.A. and L.N.). Each item in the quality appraisal
was assigned a score of 1, and the overall total score was calculated for each article. Any
uncertainty between the reviewers was resolved by discussion to reach an agreement on
the final assessment. Data on aims and objectives, methods, study population, nature of
the intervention, outcome measures, the phenomena of interest and results were extracted
from the included studies.
2.4. Data Synthesis
Due to the heterogeneity of study designs used and the outcomes measured, a meta-
analysis of the data could not be conducted. Instead, a narrative synthesis of the data is
presented according to the Synthesis Without Meta-analysis (SWiM) guidelines [30]. Studies
were grouped according to the outcomes reported and study design. Where there was
similarity in the outcomes reported and methods of reporting, these findings were compared,
and p-values, when reported, were included. Where they differed, the outcomes were grouped
by type of outcome, e.g., glycaemic control and the direction of the finding reported. Studies
of higher methodological quality were reported first in each section. Where findings were
reported from lower-quality studies, a sentence to highlight this has been added. The nature
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of the data reported did not allow for an examination of heterogeneity in reported effects or
for an assessment of the certainty of the synthesised findings.
3. Results
3.1. Study Inclusion
Figure 1 illustrates the flow of studies identified, screened, included, and the
reasons for exclusion. A systematic search found a total of 10,449 records. Duplicates
(n = 4098) were excluded. A total of 6351 records were eligible for the title and abstract
screening. Full-text screening of 35 studies yielded 22 eligible studies [20–25,31–46].
After a quality appraisal, seven studies [25,41–46] were excluded following a collective
agreement between authors that the quality of the studies was too low to merit inclusion.
Therefore, 15 studies [20–24,31–40] were included in the final synthesis.
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3.2. Characteristics of Included Studies
The review included 14 quantitative studies [20–24,31–39] and one qualitative
article [40]. Ten studies were quasi-experimental [20–24,31,32,34,35,38], four were
RCTs [33,36,37,39] and one was a process evaluation study (qualitative) [40]. Two
studies were conducted in New Zealand [39,40], 11 in Iran [20–24,31,32,34–37] and two
in the United States [33,38]. The 15 included studies comprised 684 participants, with
sample sizes ranging from 20 [38] to 118 [39]. Twelve studies were conducted in a
community setting [20,21,23,24,31–34,36,38–40], two in hospital settings [22,37], and one
in a research centre [35]. See Appendix A for an overview of the study characteristics.
3.3. Methodological Quality of Included Studies
The assessment of the methodological quality of the studies using the JBI checklist [29]
is presented in Tables 1–3. Of the ten quasi-experimental studies (maximum quality score
9), four studies were assigned a score of 8 [21,24,31,35], three studies scored 7 [20,22,23],
and the remaining studies scored 6 [32] and 5 [34], respectively. There were four RCTs
(maximum quality score 13), with two studies scoring 8 [36,37] and two scoring 10 [33,39].
The qualitative study scored 8/10. Two studies [39,40] related to the same sample but
reported different outcomes.
Table 1. JBI Critical Appraisal Checklist for Quasi-experimental studies.
Citation Q1 Q2 Q3 Q4 Q5 Q6 Q7 Q8 Q9 Score /9
[20] Y U U Y Y Y Y Y Y 7/9
[21] Y Y N Y Y Y Y Y Y 8/9
[31] Y Y N Y Y Y Y Y Y 8/9
[22] Y Y U Y Y U Y Y Y 7/9
[32] Y U U Y Y U Y Y Y 6/9
[23] Y Y Y Y Y U Y Y U 7/9
[34] Y Y U U Y U U Y Y 5/9
[35] Y Y N Y Y Y Y Y Y 8/9
[24] Y Y N Y Y Y Y Y Y 8/9
[38] Y U U N Y Y NA Y Y 5/9
Note: Y, yes; N, no; U, unclear; N.A.; not applicable. Questions: 1. Is it clear in the study what is the ‘cause’
and what is the ‘effect’ (i.e., there is no confusion about which variable comes first)? 2. Were the participants,
included in any comparisons, similar? 3. Were the participants, included in any comparisons, receiving similar
treatment/care, other than the exposure or intervention of interest? 4. Was there a control group? 5. Were there
multiple measurements of the outcome both pre- and post- intervention/exposure? 6. Was follow up complete
and, if not, were differences between groups in terms of their follow up adequately described and analysed? 7.
Were the outcomes of participants included in any comparisons measured in the same way? 8. Were outcomes
measured in a reliable way? 9. Was appropriate statistical analysis used?
Table 2. JBI Critical Appraisal Checklist for Qualitative studies.
Citation Q1 Q2 Q3 Q4 Q5 Q6 Q7 Q8 Q9 Q10 Score /10
[40] Y Y Y Y Y N U Y Y Y 8/10
Note Y, yes; N, no; U, unclear. Questions: 1. Is there congruity between the stated philosophical perspective and
the research methodology? 2. Is there congruity between the research methodology and the research question or
objectives? 3. Is there congruity between the research methodology and the methods used to collect data? 4. Is
there congruity between the research methodology and the representation and analysis of the data? 5. Is there
congruity between the research methodology and the interpretation of the results? 6. Is there a statement locating
the researcher culturally or theoretically? 7. Is the influence of the researcher on the research, and vice-versa,
addressed? 8. Are participants, and their voices, adequately represented? 9. Is the research ethical, according to
current criteria, or for recent studies, and is there evidence of ethical approval by an appropriate body? 10. Do the
conclusions drawn in the research report flow from the analysis or interpretation of the data?
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Table 3. JBI Critical Appraisal Checklist for randomised controlled trial studies.
Citation Q1 Q2 Q3 Q4 Q5 Q6 Q7 Q8 Q9 Q10 Q11 Q12 Q13 Score /13
[33] Y Y Y U U U Y Y Y Y Y Y Y 10/13
[36] Y Y Y N N N N Y Y Y Y Y Y 8/13
[37] Y Y Y N N N N Y Y Y Y Y Y 8/13
[39] Y Y Y N N U Y Y Y Y Y Y Y 10/13
Note Y, yes; N, no; U, unclear; N.A.; not applicable. 1.Was true randomization used for assignment of participants to treatment groups?
2. Was allocation to treatment groups concealed? 3. Were treatment groups similar at the baseline? 4. Were participants blind to treatment
assignment? 5. Were outcomes assessors blind to treatment assignment? 6. Were outcomes assessors blind to treatment assignment?
7. Were treatment groups treated identically other than the intervention of interest? 8. Was follow up complete and, if not, were differences
between groups in terms of their follow up adequately described and analyzed? 9. Were participants analysed in the groups to which they
were randomized? 10. Were outcomes measured in the same way for treatment groups? 11. Were outcomes measured in a reliable way?
12.Was appropriate statistical analysis used?
3.4. Review Findings
Thirteen studies reported ACT as an intervention for people living with
T2DM [20,21,23,24,31,33–40]. Only two of the studies included those living with CVD,
specifically coronary artery disease [22] and angina pectoris [32]. Eleven studies com-
pared an ACT intervention to a control (standard care or waiting list) group. Three
studies [33,37,39] compared an education plus ACT group to an education-only group,
and one study [23] compared a healthy lifestyle with ACT group to a mindfulness-based
group and a control group.
The interventions ranged from 6.5 h of ACT over one day [39] to 36 h of ACT over
12 sessions [23]. In two studies [20,32], the duration of the intervention sessions was
unknown, although most of the ACT interventions were delivered over eight sessions
of 90 min duration [21,22,24,34–36]. Three studies reported delivering a one day ACT
workshop providing 8 [38] or 6.5 [39,40] hours, or an unspecified time period over one
day [37] of ACT intervention. All interventions were delivered face-to-face in a group
setting [20–24,31–39]. Only four studies reported which had delivered ACT interven-
tions. In two studies [39,40], the intervention was delivered by a mental health nurse
with expertise in ACT, while Gregg et al. [33] reported that the intervention was deliv-
ered by the author of a diabetes and ACT manual. Maghsoudi et al. [36] report that a
clinical psychologist and nurse delivered the intervention, while a psychology doctorate
student delivered the intervention [38]. Only two studies [33,39] reported expertise or
training in ACT before intervention delivery. The primary and secondary outcomes
assessed varied and included: glycaemic control [23,33,37,39], general self-management
of T2DM [23,33,37,38], quality of life [20,21], stress [20,35], coping strategies [20], accep-
tance [37], depression [31], emotional distress [36], emotional control [24], knowledge
related to diabetes and self-management [40], mental health [34], resilience [35] and
self-efficacy [35].
Of the four studies evaluating the impact of the ACT intervention on glycaemic
control [23,33,37,39], three observed a significant improvement related to an increase
in self-care activities and reduction in glycated haemoglobin [23,33,39]. Four studies
evaluated the effect of ACT on self-management behaviour such as weight reduction,
dietary changes, exercise plans and glucose monitoring [23,33,37,38], and all reported a
significant improvement in diabetes self-care and an increase in the number of people
with glycated haemoglobin in the target range [23,33,37,38]. No significant difference in
quality of life between the intervention and control groups was reported [20,21], but ACT
significantly reduced stress levels in the two studies reporting this outcome [20,35]. A
significant improvement in all other outcomes at follow-up were reported, except for those
reported by Welch [38] (see Appendix A).
Thirteen studies reported attrition or completion rates, which ranged from 72% com-
pletion [39] to 100% [20–24,31,34–36]. The qualitative study [40] reported that most par-
ticipants (66%) described an increase in knowledge around diabetes self-management
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and an increased sense of personal responsibility. Participants also described changes in
self-management activities and reflected on the challenges in instigating and maintaining
change to improve diabetes management. The delivery of ACT in a face-to-face group
setting was described as acceptable by most participants [40].
4. Discussion
This is the first scoping review to explore the research evidence for ACT as an inter-
vention for people living with CVD and/or T2DM. ACT was consistently associated with
improved outcomes for people living with CVD or T2DM. There is emerging evidence
that ACT may be effective in improving glycaemic control, self-management and stress
reduction, with some supportive higher-quality studies. This approach offers promise
to support patients and personalise their care regarding their psychological needs, and
in doing so, may improve self-management behaviours and clinical outcomes. However,
further high-quality research is required on this topic through studies that are adequately
powered and well designed, for example, RCTs and process evaluations.
Strengths of this review include the thorough search strategy and the number of
full-texts assessed, which included study language translation to ensure inclusivity of all
published evidence. The review followed accepted guidelines for conducting a scoping
review, and we included a robust process of quality appraisal to acknowledge and raise
awareness of the quality of the papers included in the review.
The paucity of studies using RCT designs, small sample sizes (resulting in lack of
power), and the generally low quality of studies meant it was unclear whether the findings
were due to the intervention, non-specific therapy factors, placebo effects, or regression
to the mean. This must be taken into consideration when interpreting the results of the
review. While findings to date are encouraging, further high-quality research is needed.
Researchers and article authors would benefit from adhering to the reporting standards for
intervention studies [48].
In addition to the quality of the studies reported, much variability existed in the
sample size, the mode of delivery, the length of the intervention, outcomes measured
and reported. The low intensity of the intervention delivery is noteworthy given that
all the interventions were delivered as a group, and in this context, may align well into
standard diabetes and CVD care approaches. A previous review [14] on ACT across
any long-term condition noted the brief administration of ACT sessions as a limitation
(highlighting that 58% of interventions included five or fewer sessions). In this review,
most of the studies aligned themselves to a clear ACT protocol; however, detail on the
implementation of the intervention, explicitly who delivered the ACT intervention and
if they were trained to deliver ACT, was poorly reported. None of the studies examined
ACT in people living with the comorbidity of heart disease and diabetes. Only one
study assessed the acceptability [40] of the intervention. The evidence regarding ACT
and outcomes are ambivalent. Most studies were pre-test post-test in design making the
assessment of causality challenging. Studies that included a longitudinal or cohort design
reported inconclusive results. Furthermore, most of the studies were conducted in Iran,
although evidence was included from studies conducted in the United States of America,
Australia, and New Zealand. However, the results may not be directly applicable to other
cultures and healthcare systems.
5. Conclusions
The review reported improved outcomes for people living with CVD or T2DM and that
ACT was an acceptable and valid intervention. ACT provides an alternative approach that
warrants further assessment in relation to effectiveness. High quality research is needed to
further assess the effectiveness of ACT to improve patient reported and clinical outcomes.
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Appendix A
Table A1. Characteristics of Included Studies for the Scoping Review.
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